Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06910956 · ClinicalTrials.gov registry record · NA
Deep Learning Using Chest X-Rays to Identify High Risk Patients for Lung Cancer Screening CT
A NA study of Lung Cancer and Early Cancer Detection, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 1,500
- Enrollment target
- 1
- Study location
NCT06910956: Recruiting NA study of Lung Cancer and Early Cancer Detection, sponsored by Massachusetts General Hospital.
NCT06910956 is a NA study of Lung Cancer and Early Cancer Detection that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 1,500 participants, above the 932-participant average among 409 other Lung Cancer trials with a reported enrollment target (61% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06910956, a NA study of Lung Cancer and Early Cancer Detection, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,500 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to evaluate whether an AI tool that alerts providers to patients at high 6-year risk of lung cancer based on their chest x-ray images will improve lung cancer screening CT participation. The main question it aims to answer is: Does the AI tool improve lung cancer screening CT participation at 6 months after the baseline outpatient visit The intervention is an alert to the provider to discuss lung cancer screening CT eligibility, for patients considered at high risk of lung cancer based on CXR-LC AI tool. If there is a comparison group: Researchers will compare intervention and non-intervention arms to determine if lung cancer screen CT participation increases.
Conditions Studied
Interventions
- OTHER CXR-LC
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2025-05-20 |
| Est. Completion | 2027-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06910956
The ClinicalTrials.gov registry entry for NCT06910956 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 932-participant average among 409 other Lung Cancer trials with a reported enrollment target (61% higher). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which CXR-LC is the first listed.
NCT06910956 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06910956 about?
NCT06910956 is a clinical study titled "Deep Learning Using Chest X-Rays to Identify High Risk Patients for Lung Cancer Screening CT". The goal of this clinical trial is to evaluate whether an AI tool that alerts providers to patients at high 6-year risk of lung cancer based on their chest x-ray images will improve lung cancer screening CT participation. The main question it aims to answer is: Does the AI tool improve lung cancer s...
What is the current status of trial NCT06910956?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,500 participants. The study started on 2025-05-20. Estimated completion is 2027-07-01.
What conditions does trial NCT06910956 study?
This clinical trial studies the following conditions: Lung Cancer, Early Cancer Detection, Health Screening, Deep Learning.
What interventions are being tested in trial NCT06910956?
The interventions under investigation include: CXR-LC (OTHER).
Who is sponsoring clinical trial NCT06910956?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06910956 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.